We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more
SAN JOSE, Calif., Sept. 03, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
- Announced partnership with ProGen on development of RT-114, an oral GLP-1/GLP-2 dual agonist for the treatment of obesity - - Phase 1 study for RT-114 expected to initiate in 2025...
SAN JOSE, Calif., July 29, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
SAN JOSE, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.23 | -9.82905982906 | 2.34 | 2.6 | 2.02 | 80185 | 2.23300661 | CS |
4 | -0.9 | -29.9003322259 | 3.01 | 3.6 | 2.02 | 75894 | 2.61988939 | CS |
12 | -1.64 | -43.7333333333 | 3.75 | 4.19 | 2.02 | 56518 | 2.90725767 | CS |
26 | -1.19 | -36.0606060606 | 3.3 | 8.75 | 2.02 | 100437 | 5.1249581 | CS |
52 | -0.79 | -27.2413793103 | 2.9 | 8.75 | 1.82 | 93901 | 4.13219723 | CS |
156 | -15.89 | -88.2777777778 | 18 | 36.27 | 1.82 | 65651 | 7.87092188 | CS |
260 | -9.15 | -81.2611012433 | 11.26 | 36.27 | 1.82 | 83096 | 10.59233469 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions